Synthesis and bioactivities of multiple antigenic peptide vaccines containing two different schistosomal antigenic peptides

Yaoxue Xuebao

Volumn 34, Issue 10, 1999, Pages 751-754

  Cao, Shengli ^a   Cai, Mengshen ^a   Shi, Youen ^b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Multiple antigenic peptide; Schistosome; Synthetic peptide vaccine

Indexed keywords

EID: 0346617054     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Cao SL, Qin ZH, Cai MS. Syntheses and bioactivities of multiple antigenic peptide vaccines against Schistosomiasis. Acta Pharm Sin, 1999,34:368
2. Wolowczuk I, Auriauit C, Gras-Masse H, et al. Protective immunity in mice vaccinated with the Schistosoma mansoni P-28-1. J Immunol, 1989,142:1342
3. Auriault C, Gras-Masse H, Wolowczuk I, et al. Analysis of T and B cell epitopes of the Schistosoma mansoni P28 antigen in the rat model by using synthetic peptides. J Immunol, 1988,141:1687
4. Auriault C, Gras-Masse H, Pierce RJ, et al. Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 Glutathione-S-transferase and to synthetic peptides. J Clin Microbiol, 1990,28:1918
5. Dunne DW, Hagan P, Abath FGC. Prospects for immunological control of schistosomiasis. Lancet, 1995, 345:1488
6. Tam JP. Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system. Proc Natl Acad Sci USA, 1988,85:5409
7. Sarin VK, Kent SBH, Tam JP. Quantitative monitoring of solid-phase peptide synthesis by the ninhydrin reaction. Anal Biochem, 1981,117:147
8. 2 deprotection of synthetic peptide with a low concentration of HF in dimethyl sulfide: evidence and application in peptide synthesis. J Am Chem Soc, 1983,105:6442
9. Zhao WX. Human Parasitology. The second edition. Beijing: People's Medical Publishing House, 1994.370-378